Court smooths over Botox trade mark dispute with Freezeframe injunction

Angus Lang 2021-10-13 8:47 pm By Bianca Hrovat | Sydney

Please login to bookmark

Botox drug maker Allergan has secured an injunction against a Sydney-based cosmetics company which sought to “leverage” the reputation of the well-known injectable to sell its Freezeframe line of anti-aging topical creams.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au